John D Imig Selected Research

angiotensin A

11/2010

20-hydroxyeicosatetraenoic acid and angiotensin: a positive feedback system to cause hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John D Imig Research Topics

Disease

81	Hypertension (High Blood Pressure) 01/2022 - 01/2002
24	Inflammation (Inflammations) 01/2022 - 10/2007
18	Fibrosis (Cirrhosis) 01/2022 - 12/2004
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 05/2004
11	Albuminuria 01/2019 - 08/2004
10	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2018 - 01/2005
9	Chronic Renal Insufficiency 03/2021 - 01/2005
9	Proteinuria 01/2021 - 03/2006
7	Kidney Diseases (Kidney Disease) 01/2022 - 12/2009
7	Obesity 01/2021 - 10/2003
6	Heart Failure 08/2021 - 10/2018
6	Insulin Resistance 10/2018 - 06/2007
5	Diabetic Nephropathies (Diabetic Nephropathy) 11/2021 - 06/2007
5	Myocardial Infarction 01/2019 - 06/2012
5	Malignant Hypertension 10/2018 - 01/2011
5	Body Weight (Weight, Body) 12/2015 - 08/2004
4	Cardiomegaly (Heart Hypertrophy) 01/2021 - 08/2007
4	Neoplasms (Cancer) 11/2020 - 10/2007
4	Type 2 Diabetes Mellitus (MODY) 10/2018 - 08/2004
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2015 - 04/2002
3	Reperfusion Injury 01/2022 - 11/2018
3	COVID-19 01/2022 - 01/2022
3	Renovascular Hypertension (Goldblatt Syndrome) 01/2016 - 01/2012
3	Stroke (Strokes) 03/2011 - 12/2005
2	Hypoxia (Hypoxemia) 01/2022 - 11/2018
2	Pneumonia (Pneumonitis) 01/2022 - 12/2018
2	Post-Acute COVID-19 Syndrome 01/2022 - 01/2022
2	Thromboinflammation 01/2022 - 01/2022
2	Fistula 08/2021 - 01/2019
2	Alcoholic Fatty Liver 01/2021 - 01/2019
2	Ureteral Obstruction 10/2020 - 05/2016
2	Diabetes Mellitus 01/2020 - 04/2002
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 07/2006
2	Liver Diseases (Liver Disease) 01/2019 - 10/2018
2	Infarction (Infarctions) 11/2018 - 06/2009
2	Hyperglycemia 11/2018 - 11/2017
2	Hypertrophy 03/2015 - 02/2010

Drug/Important Bio-Agent (IBA)

34	Epoxide HydrolasesIBA 01/2022 - 02/2002
30	AcidsIBA 01/2022 - 09/2005
28	Angiotensin IIIBA 08/2021 - 01/2002
18	SaltsIBA 01/2020 - 03/2003
16	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 02/2002
16	AngiotensinsIBA 10/2017 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
14	EnzymesIBA 01/2019 - 03/2003
11	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 10/2018 - 03/2003
10	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 01/2021 - 01/2007
8	CollagenIBA 01/2021 - 12/2007
8	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 02/2006
7	LipidsIBA 01/2022 - 10/2007
7	ReninIBA 10/2018 - 02/2010
6	14,15-epoxy-5,8,11-eicosatrienoic acidIBA 01/2022 - 10/2015
6	EicosanoidsIBA 10/2020 - 10/2003
6	indole-3-carbinolIBA 10/2018 - 01/2011
5	Pharmaceutical PreparationsIBA 03/2021 - 12/2009
5	Streptozocin (Streptozotocin)FDA Link 01/2019 - 11/2011
5	Arachidonic Acid (Vitamin F)IBA 12/2018 - 01/2005
5	XenobioticsIBA 10/2018 - 08/2011
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2022 - 08/2004
4	SodiumIBA 01/2022 - 01/2007
4	Blood Glucose (Blood Sugar)IBA 11/2021 - 08/2004
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2020 - 07/2011
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 06/2007
4	salicylhydroxamic acid (SHAM)IBA 01/2020 - 03/2010
4	EET-BIBA 01/2019 - 11/2013
4	Epoxy Compounds (Epoxides)IBA 09/2013 - 02/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2010 - 03/2006
3	Biological ProductsIBA 01/2022 - 01/2006
3	Enalapril FDA LinkGeneric 11/2021 - 02/2007
3	Messenger RNA (mRNA)IBA 08/2021 - 01/2019
3	nephrinIBA 01/2021 - 09/2009
3	Sorafenib (BAY 43-9006)FDA Link 01/2021 - 05/2012
3	Epithelial Sodium ChannelsIBA 01/2020 - 09/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 10/2007
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2011
3	ProstaglandinsIBA 09/2013 - 10/2007
3	Benzoic Acid (Potassium Benzoate)FDA Link 06/2012 - 09/2009
3	Vasoconstrictor AgentsIBA 02/2010 - 01/2002
3	Desoxycorticosterone Acetate (DOCA)FDA Link 09/2009 - 01/2008
3	Cysteine (L-Cysteine)FDA Link 10/2008 - 10/2007
3	Matrix Metalloproteinases (MMPs)IBA 10/2008 - 02/2006
3	Interleukin-6 (Interleukin 6)IBA 10/2008 - 03/2006
3	cytochrome P-450 CYP2C subfamilyIBA 03/2006 - 10/2003
2	Prostaglandin D2IBA 01/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2022
2	ramatrobanIBA 01/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2005
2	Substance PIBA 10/2021 - 01/2019
2	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 08/2013
2	CalciumIBA 01/2021 - 09/2005
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2020 - 05/2016
2	CreatinineIBA 01/2019 - 01/2018
2	CytokinesIBA 01/2019 - 12/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2018 - 05/2012
2	Captopril (Capoten)FDA LinkGeneric 04/2016 - 05/2012
2	Malondialdehyde (Propanedial)IBA 01/2016 - 08/2014
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016 - 08/2014
2	AndrogensIBA 03/2015 - 01/2009

Therapy/Procedure

11	Therapeutics 10/2021 - 04/2004
4	Surgical Instruments (Clip) 10/2015 - 03/2010